Sera Prognostics Inc - Ordinary Shares Class A

NASDAQ:SERA 4:00:00 PM EDT

10.04

+0.08 (+0.80%)

4:00:01 PM EDT: $10.04 0.00 (0.00%)

Market Cap (Intraday)	328.16M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.07 Million
Adjusted EPS	-$0.27

See more estimates

10-Day MA	$9.90
50-Day MA	$9.39
200-Day MA	$4.92

See more pivots

Sera Prognostics Inc - Ordinary Shares Class A Stock, NASDAQ:SERA

2749 East Parleys Way, Suite 200, Salt Lake City, Utah 84109

United States of America

Phone: +1.801.990.0520

Number of Employees: 57

http://www.seraprognostics.com

Description

Sera Prognostics, Inc. engages in the provision of personalized diagnostics to predict and manage pregnancy complications. It focuses on developing blood tests to predict the risks of preterm birth, preeclampsia and other pregnancy complications. The company was founded by Steven W. Graves, Dennis Farrar and M. Sean Esplin in 2008 and is headquartered in Salt Lake City, UT.